Benjamin Rix Brooks

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Venues

Amyotrophic lateral sclerosis & frontotemporal degeneration

Atrium Health Neurosciences Institute - Carolinas Medical Center - University of North Carolina School of Medicine - Charlotte Campus

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Atrium Health Neurosciences Institute - Carolinas Medical Center - University of North Carolina School of Medicine - Charlotte Campus Feb 01 2008

United States

Medical Director - Professor :: Neurology - Neuromuscular/ALS MDA CARE Center

Publications

Benjamin Rix Brooks
Letter to the Editor: Glycemic Index/Load Effect on Amyotrophic Lateral Sclerosis Progression: Potential Interaction with Riluzole. Annals of neurology 96 (1) (2024)
Benjamin Rix Brooks
Letter to the Editor: Glycemic Index/Load Effect on Amyotrophic Lateral Sclerosis Progression: Potential Interaction with Riluzole. Annals of neurology (2024)
Kathryn A Kvam, Michael Benatar, Alisa Brownlee, Tracie Caller, Rohit R Das, Phil Green, Sherry Kolodziejczak, John Russo, Danica Sanders, Nadia Sethi, Kara Stavros, Julie Stierwalt, Nancy Giles Walters, Amy Bennett, Scott R Wessels, Benjamin Rix Brooks
Amyotrophic Lateral Sclerosis Quality Measurement Set 2022 Update: Quality Improvement in Neurology. Neurology 101 (5) (2023)
Benjamin Rix Brooks, Erik P Pioro, Takeshi Sakata, Fumihiro Takahashi, Melissa Hagan, Stephen Apple
The effects of intervention with intravenous edaravone in Study 19 on hospitalization, tracheostomy, ventilation, and death in patients with amyotrophic lateral sclerosis. Muscle & nerve (2023)
Benjamin Rix Brooks, Terry Heiman-Patterson, Martina Wiedau-Pazos, Shawn Liu, Jeffrey Zhang, Stephen Apple
Edaravone efficacy in amyotrophic lateral sclerosis with reduced forced vital capacity: Post-hoc analysis of Study 19 (MCI186-19) [clinical trial NCT01492686]. PloS one 17 (6) (2022)
Paul Mehta, Jaime Raymond, Moon Han, Reshma Punjani, Theodore Larson, James D Berry, Benjamin Rix Brooks, Björn E Oskarsson, Stephen A Goutman, Kevin Horton
A revision to the United States national ALS registry's algorithm to improve Case-Ascertainment. Amyotrophic lateral sclerosis & frontotemporal degeneration (2022)
Björn E Oskarsson, Nicholas J Maragakis, Richard Stanley Bedlack, Namita A Goyal, Jenny A Meyer, Angela Genge, Cynthia Bodkin, Samuel Maiser, Nathan P Staff, Lorne Zinman, Nicholas T Olney, John Turnbull, Benjamin Rix Brooks, Emelia Klonowski, Malath Makhay, Seiichi Yasui, Kazuko Matsuda
MN-166 (ibudilast) in amyotrophic lateral sclerosis in a Phase IIb/III study: COMBAT-ALS study design. Neurodegenerative disease management (2021)
Jinsy A Andrews, Carlayne E Jackson, Terry D Heiman-Patterson, Paolo Bettica, Benjamin Rix Brooks, Erik P Pioro
Real-world evidence of riluzole effectiveness in treating amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis & frontotemporal degeneration 21 (7-8) (2020)

Benjamin Rix Brooks.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Benjamin Rix Brooks